Company / Capital Expenditures
Quest Diagnostics Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$527.0M
FY2025
5-year range
$400.0M / $527.0M
FY2021-FY2025
Trend
+24.0%
vs FY2024
Sector context
#23 of 151
Health Care
What the data says
Quest Diagnostics's capital expenditures of $527M is higher than 85% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $252M in FY2019 to $527M in FY2025.
Based on SEC 10-K filings.
$527M in FY2025 with a 5-year CAGR of +4.7%. Top quartile in the Health Care sector.
Improved from $403M to $527M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
+94.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.7%, indicating consistent growth.
- In FY2025, capital expenditures increased 24.0% year-over-year.
- Ranks #23 out of 151 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $527.0M | +24.0% |
| FY2024 | $425.0M | +5.5% |
| FY2023 | $403.0M | -3.6% |
| FY2022 | $418.0M | +4.5% |
| FY2021 | $400.0M | -4.3% |
| FY2020 | $418.0M | +65.9% |
| FY2019 | $252.0M | -14.0% |
| FY2018 | $293.0M | +11.4% |
| FY2017 | $263.0M | -14.6% |
| FY2016 | $308.0M | +33.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026